Cell Source, Inc. (CLCS)
OTCMKTS: CLCS · Delayed Price · USD
0.300
-0.100 (-25.00%)
Aug 30, 2024, 12:49 PM EDT - Market closed
Cell Source Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | 2023 | 2022 | 2021 | 2020 | 2019 |
| Aug '24 Aug 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 19 | 18 | 30 | 43 | 64 | 29 | |
| Market Cap Growth | 25.46% | -40.09% | -30.67% | -32.39% | 119.45% | 50.64% | |
| Enterprise Value | 29 | 28 | 37 | 50 | 68 | 31 | |
| Last Close Price | 0.45 | 0.46 | 0.85 | 1.28 | 2.00 | 1.10 | |
| PE Ratio | - | -2.65 | -4.68 | -6.58 | -10.70 | -5.97 | |
| PB Ratio | 0.00 | -1.15 | -2.37 | -4.40 | -8.04 | -5.07 | |
| P/FCF Ratio | -0.01 | -7.65 | -9.55 | -12.79 | -23.04 | -11.26 | |
| P/OCF Ratio | -0.01 | -7.65 | -9.55 | -12.79 | -23.04 | -11.26 | |
| EV/EBIT Ratio | -2.30 | -6.59 | -8.88 | -12.41 | -18.65 | -8.20 | |
| EV/FCF Ratio | -4.19 | -11.74 | -11.82 | -14.76 | -24.45 | -12.06 | |
| Debt / Equity Ratio | -0.58 | -0.60 | -0.63 | -0.66 | -0.60 | -0.47 | |
| Debt / FCF Ratio | -4.35 | -3.96 | -2.52 | -1.92 | -1.73 | -1.04 | |
| Quick Ratio | 0.01 | 0.00 | 0.02 | 0.01 | 0.03 | 0.00 | |
| Current Ratio | 0.02 | 0.01 | 0.03 | 0.03 | 0.05 | 0.02 | |
| Return on Assets (ROA) | -661.78% | -864.18% | -721.27% | -655.68% | -801.86% | -2634.10% | |
| Earnings Yield | -34.17% | -29.64% | -17.25% | -12.66% | -7.13% | -15.37% | |
| FCF Yield | -12.18% | -13.08% | -10.47% | -7.82% | -4.34% | -8.88% | |
| Buyback Yield / Dilution | -9.41% | -8.47% | -5.19% | -13.81% | -2.72% | -2.83% | |
| Total Shareholder Return | -9.41% | -8.47% | -5.19% | -13.81% | -2.72% | -2.83% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.